BSX Boston Scientific RESULTS: Q2, Q2 Net Income $905M, Q2 REV $5.442B vs. EST $5.361B, Q2 EPS $0.61, Q2 ADJ EPS $0.86 vs. EST $0.83, Boston

BSX Boston Scientific RESULTS: Q2, Q2 Net Income $905M, Q2 REV $5.442B vs. EST $5.361B, Q2 EPS $0.61, Q2 ADJ EPS $0.86 vs. EST $0.83, Boston Scientific Earnings Notes:, Outlook FY organic REV growth 5-6%, Outlook FY ADJ EPS $3.28-3.32 vs. EST $3.36, Outlook FY REV growth 5.5-6.5%